-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Mass vaccination of the new crown vaccine has significantly reduced the risk of death for patients with new crown pneumonia
The new crown pneumonia recently researchers examined the effect of intensive vaccination against Israel's new crown pneumonia mortality
The researchers collected data on people over 50 in the Clalit database.
A total of 843208 participant data were collected, of which 758118 (90%) received booster injections during the 54-day study period
65 participants in the strengthening group and 137 participants in the control group died due to Covid-19 (the risk of death was 0.
Intensified needles significantly reduce the risk of death from new coronary pneumonia
Intensified needle significantly reduces the risk of death from new coronary pneumonia Enhanced needle greatly reduces the risk of death from new coronary pneumoniaStudies believe that in people who have completed the BNT162b2 vaccination for at least 5 months, the third shot can reduce the risk of death from new coronary pneumonia by 90%
In people who have completed the BNT162b2 vaccination for at least 5 months, the third shot can reduce the risk of death from new coronary pneumonia by 90%
Ronen Arbel et al.
BNT162b2 Vaccine Booster and Mortality Due to Covid-19.
Leave a message here